Therefore, we predict that mutations in the ARID1B gene would result in decreased expression of wild-type protein, relatively enhanced activity of ARIDIA protein, low expression of FGFR3 protein, and low expression of COL2A1 protein leading to clinical phenotypes associated with myopia. This evidence concerns the gene ARID1B and myopia.